Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray Medir pharmaceutical Midazolam Nasal Spray

Nazolam Home




MEDIR is a specialty pharmaceutical company, seeking to address the areas of high unmet medical needs in: 1. inducing mild sedation in a safe, convenient and needle free way; and 2. offering a treatment for acute epileptic seizure control outside a hospital setting, that is fast, efficacious and easy adminstered.
The company has developed nasal sprays (trademark: Nazolam) containing midazolam, a compound that currently needs to be administered by intravenous injection for predicitive results. 


This product is already available for patients in the Netherlands and known as Midazolam 2,5 mg unit dose neusspray (Z-index number: 16.532.430) or Midazolam 5 mg unit dose neusspray (Z-Index number: 16.367.898) manufactured by GMP Apotheek De Magistrale Bereider and distributed through Fagron Nederland. This nasal spray is fully reimbursed in the Netherlands.


Device picture: property and courtesy of Aptar Pharma


© 2017 Medir. All rights reserved.